Synjardy 500 mg/1

Synjardy 500 mg/1 tablets combine empagliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Synjardy 500 mg/1 tablets are designed to help manage type 2 diabetes by improving blood sugar levels. This combination medication works by enhancing the body's response to insulin and reducing sugar absorption in the kidneys. It is typically used alongside diet and exercise for comprehensive diabetes management.

Common effects of Synjardy 500 mg/1 tablets may include urinary tract infections, nausea, and diarrhea. Some individuals might experience low blood sugar levels, especially when combined with other diabetes medications. Always consult a healthcare provider for personalized advice.

Handle Synjardy 500 mg/1 tablets with care, especially if you have kidney issues or are prone to low blood sugar. Avoid alcohol while taking this medication, as it can increase the risk of side effects. Store the tablets at room temperature, away from moisture and heat.

Synjardy 500 mg/1 tablets may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Always inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol can also increase the risk of side effects.